474 related articles for article (PubMed ID: 29203116)
1. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
4. Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
Pentheroudakis G; Spector Y; Krikelis D; Kotoula V; Meiri E; Malamou-Mitsi V; Fountzilas G; Sanden M; Pavlidis N; Benjamin H; Aharonov R
Clin Exp Metastasis; 2013 Apr; 30(4):431-9. PubMed ID: 23124598
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of carcinoma of unknown primary in the head and neck.
Issing WJ; Taleban B; Tauber S
Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):436-43. PubMed ID: 12684829
[TBL] [Abstract][Full Text] [Related]
6. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP.
Pavlidis N; Pentheroudakis G; Plataniotis G
Clin Transl Oncol; 2009 Jun; 11(6):340-8. PubMed ID: 19531448
[TBL] [Abstract][Full Text] [Related]
7. [Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].
Bugat R; Bataillard A; Lesimple T; Voigt JJ; Culine S; Lortholary A; Merrouche Y; Ganem G; Kaminsky MC; Negrier S; Perol M; Laforêt C; Bedossa P; Bertrand G; Coindre JM; Fizazi K;
Bull Cancer; 2002 Oct; 89(10):869-75. PubMed ID: 12441278
[TBL] [Abstract][Full Text] [Related]
8. CUP (carcinoma of unknown primary) syndrome in head and neck: clinic, diagnostic, and therapy.
Weber A; Schmoz S; Bootz F
Onkologie; 2001 Feb; 24(1):38-43. PubMed ID: 11441279
[TBL] [Abstract][Full Text] [Related]
9. [Unknown primary cancer].
Furue H
Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
[TBL] [Abstract][Full Text] [Related]
10. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
[TBL] [Abstract][Full Text] [Related]
11. Metastatic cancer with unknown primary.
Greenberg BR; Lawrence HJ
Med Clin North Am; 1988 Sep; 72(5):1055-65. PubMed ID: 2842554
[TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902
[TBL] [Abstract][Full Text] [Related]
13. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
Jereczek-Fossa BA; Jassem J; Orecchia R
Cancer Treat Rev; 2004 Apr; 30(2):153-64. PubMed ID: 15023433
[TBL] [Abstract][Full Text] [Related]
14. Treatment for patients with unknown primary cancer and favorable prognostic factors.
Hainsworth JD; Fizazi K
Semin Oncol; 2009 Feb; 36(1):44-51. PubMed ID: 19179187
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Pentheroudakis G; Briasoulis E; Kalofonos HP; Fountzilas G; Economopoulos T; Samelis G; Koutras A; Karina M; Xiros N; Samantas E; Bamias A; Pavlidis N;
Acta Oncol; 2008; 47(6):1148-55. PubMed ID: 18607872
[TBL] [Abstract][Full Text] [Related]
16. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
Hemminki K; Bevier M; Sundquist J; Hemminki A
Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
[TBL] [Abstract][Full Text] [Related]
17. Management of patients with cancer of unknown primary site.
Hainsworth JD; Greco FA
Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
[TBL] [Abstract][Full Text] [Related]
18. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.
Müller von der Grün J; Tahtali A; Ghanaati S; Rödel C; Balermpas P
Radiat Oncol; 2017 May; 12(1):82. PubMed ID: 28486947
[TBL] [Abstract][Full Text] [Related]
20. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; Marchiò C; Sapino A
Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
